Answer:
the total cost is $23,200
Explanation:
The computation of the total cost of the 2,000 units transferred is as follows:
= Total cost at that point + other cost
= $13,600 + (2,000 × (1 - 0.40) × $8)
= $13,600 + 2,000 × 60% × $8
= $13,600 + $9,600
= $23,200
hence, the total cost is $23,200
Answer: $107,900
Explanation:
Cumulative Preferred Shares refer to shares that a company has to pay dividends eventually. This means that if they are unable to pay for some years, they are to accrue that payment until they are able to.
There are 119000 shares of no-par 6% preferred stock with a stated value of $5.
That means preferred shares are liable to the following amount of dividends,
= 119,000 * 5 * 6%
= $35,700
Preferred Shares have not being paid for the past 2 years and need to be paid in the current year as well. That means 3 payments,
= 35,700 * 3
= $107,100
Preferred Shares are to be paid $107,100 out of the $215,000 with the rest going to common shares.
Amount going to Common Shares is,
= 215,000 - 107,100
= $107,900
Common Stockholders are to receive $107,900
Answer:
C = 11,420.7405
Explanation:
Loan for 37,000 at 9% in four annual payment
We have to calculate the cuota of an annuity
where rate = 0.09
time = 4
and present value is the 37,000 we receive today
C = 11,420.7405
Answer:
17
Explanation:
I believe this, but I don't really know. Sorry.
Answer:
stock price will not change at all
Explanation:
Based on the information provided it can be said that when the company releases its next earnings report the stock price will not change at all. This is because stock markets move fast, the stock price of EPS moved when the in the announcement about FDA approval was made. Therefore the markets already expect these changes to reflect on the earnings report so prices will not move. Just as the saying goes, "Buy the Rumor, Sell the news."
